Phosphofructokinase deficiency
(Redirected from Glycogenosis type VII)
Phosphofructokinase deficiency is a rare genetic disorder that affects the body's ability to break down sugar for energy. It is also known as Glycogen storage disease type VII or Tarui disease. The condition is caused by mutations in the PFK gene, which provides instructions for making an enzyme called phosphofructokinase. This enzyme is involved in a process called glycolysis, which is the first step in converting glucose into energy.
Symptoms[edit | edit source]
The symptoms of phosphofructokinase deficiency can vary widely, but they often include muscle weakness and fatigue, especially after exercise. Some people may also experience muscle cramps or pain. In severe cases, the disease can lead to a breakdown of muscle tissue, which can cause dark urine and potentially damage the kidneys. Other symptoms can include a buildup of glycogen in the muscles and liver, and in some cases, anemia.
Causes[edit | edit source]
Phosphofructokinase deficiency is caused by mutations in the PFK gene. This gene provides instructions for making an enzyme called phosphofructokinase, which is involved in the process of glycolysis. When the PFK gene is mutated, the body cannot properly break down glucose for energy, leading to the symptoms of the disease.
Diagnosis[edit | edit source]
The diagnosis of phosphofructokinase deficiency is usually made based on the symptoms, a physical examination, and laboratory tests. These tests can include a blood test to measure the levels of certain enzymes in the blood, a muscle biopsy to look for a buildup of glycogen in the muscles, and genetic testing to look for mutations in the PFK gene.
Treatment[edit | edit source]
There is currently no cure for phosphofructokinase deficiency, but treatment can help manage the symptoms. This can include a high-protein diet to help build muscle, and avoiding strenuous exercise to prevent muscle breakdown. In some cases, medications may be used to help manage symptoms.
See also[edit | edit source]
Phosphofructokinase deficiency Resources | |
---|---|
|
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD